LifCare

LifCare functions as a subscription-based pharmacy specifically targeting patients with chronic illnesses requiring ongoing medication for conditions like diabetes, cardiac issues, hypertension, and renal disorders. The business model is centered on managing medicine refills for these patients, who typically require them every 30 to 60 days. By employing data science, the company automates the refill process to improve medication adherence. This technology-driven approach also aims to create a more efficient supply chain, thereby reducing costs for the end consumer. The service includes prescription digitization, medicine reminders, intelligent warehouse stocking, and smart logistics.

The company's revenue is generated through the sale and delivery of these subscription-based medicines. LifCare's strategy was to serve as a full-service disease management platform, intending to expand beyond medicine delivery to include end-to-end services that chronic patients need. The firm secured significant financial backing, raising a total of $17 million over three funding rounds. A major funding event was a Series B round in July 2018, where it raised $11 million from investors including SAIF Partners (now Elevation Capital), Nexus Venture Partners, and IL&FS. This capital was intended to fuel geographical expansion across North, Central, and West India and to enhance its technology platform.